Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0984 | -2.31529411765 | 4.25 | 4.31 | 3.9216 | 6236 | 4.11817071 | CS |
| 4 | 0.3416 | 8.96587926509 | 3.81 | 4.6445 | 3.81 | 23173 | 4.25294492 | CS |
| 12 | 0.4116 | 11.0053475936 | 3.74 | 5.0899 | 3.5601 | 25229 | 4.07939202 | CS |
| 26 | 0.1516 | 3.79 | 4 | 5.2 | 2.78 | 18645 | 3.97294827 | CS |
| 52 | 0.6516 | 18.6171428571 | 3.5 | 5.2 | 2.78 | 11965 | 3.96983505 | CS |
| 156 | -9.1484 | -68.784962406 | 13.3 | 14.8 | 2.40101 | 50189 | 7.71854791 | CS |
| 260 | -11.8484 | -74.0525 | 16 | 58.5 | 2.40101 | 833427 | 27.88337783 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
